Last updated: September 28, 2025
Introduction
Patent RU2011142750 pertains to a pharmaceutical invention registered within the Russian Federation's patent system. As an influential component in the intellectual property (IP) landscape, understanding the scope and claims of this patent provides valuable insights into its market exclusivity, technological breadth, and potential competitive impact. This analysis aims to dissect the patent's claims, define its scope, and position it within the broader patent landscape relevant to its therapeutic field.
Patent Overview and Basic Data
- Patent Number: RU2011142750
- Application Filing Date: Likely to be around 2011, based on serial number and publication data.
- Grant Date: Precise date to be verified from official patent repositories.
- Applicant/Assignee: To be specified by patent documentation.
- Inventors: To be specified, often disclosed on the patent document.
The patent title and abstract—if available—would typically reveal the core invention, which is likely related to a pharmaceutical compound, formulation, or method of use. These elements form the foundation for scope and claim analysis.
Claims Analysis
Russian patents generally include independent and dependent claims. The scope of protection primarily hinges on independent claims, which define the broadest acceptable boundaries of the patent.
1. Nature of the Claims
-
Broadness:
The broadest independent claim likely pertains to a specific chemical entity, pharmaceutical formulation, or therapeutic method. Its language sets the legal scope, referencing structural features or process steps.
-
Dependent Claims:
These specify particular embodiments, such as specific substituents, dosages, formulations, or therapeutic indications, thereby narrowing scope but reinforcing patent coverage.
2. Typical Elements of the Claims
-
Chemical Composition Claims:
May cover the compound with specified structural formulae and purity thresholds. For example, compounds with particular substituents or stereochemistry.
-
Method Claims:
Encompass processes for synthesizing the compound or using it in therapeutic applications.
-
Formulation Claims:
Include dosage forms such as tablets, capsules, or injectable preparations, with specific excipients or delivery mechanisms.
-
Use Claims:
Claiming specific therapeutic indications or methods of treatment involving the compound.
3. Claim Language and Limitations
-
Precision and Exclusivity:
Clarity of terms such as “comprising,” “consisting of,” impacts scope—“comprising” allows additional components, broadening protection.
-
Scope Limitations:
Numerical ranges (e.g., dosage, pH), specific chemical substituents, or process parameters impact claim breadth.
-
Potential Gaps:
Overly narrow claims could permit competitors to design around; overly broad claims risk patent invalidity for lack of novelty or inventive step.
Patent Scope
Primary Focus:
Based on typical patent strategies in Russian pharmaceutical patents, RU2011142750 likely claims a novel chemical entity with specific therapeutic activity, along with associated formulations and methods of use.
Implications of Claim Scope:
-
Narrow Claims:
Offer strong protection for the specific compound or formulation but are vulnerable to design-around strategies.
-
Broad Claims:
Cover generically defined compounds or uses, providing extensive market rights but face higher risk of validity challenges.
Legal Status and Validity:
Continued maintenance and absence of oppositions bolster enforceability. Russian patent law requires annual fees and compliance with patentability criteria, which influence scope durability.
Patent Landscape Context
1. Relevant Patent Families and Infringing Patents
- The patent landscape includes domestic and international patent families related to the same or similar compounds, therapeutic classes, or formulations.
- Overlaps with patents from major players in the pharmaceutical industry, especially if the compound is a novel chemical entity with significant therapeutic potential, are common.
2. Prior Art and Patentability
- Substantive examiners assess whether the invention involves an inventive step over prior art, which includes earlier Russian and international patents, scientific publications, and known uses.
- The scope of claims must balance novelty, inventive step, and industrial applicability under Russian patent law.
3. Patent Families and Filing Strategies
- Often, applicants pursue parallel filings in multiple jurisdictions—European Patent Office (EPO), US Patent and Trademark Office (USPTO)—to extend global protection.
- Russian patent RU2011142750’s international family members could include patents in Eurasia, Commonwealth of Independent States (CIS), and potentially China or patent cooperation treaty (PCT) applications.
Legal and Commercial Implications
- The patent’s scope affects licensing opportunities and generics entry.
- Narrow claims may necessitate supplementary patents with narrower or alternative claims to maintain market exclusivity.
- The patent’s expiration date—likely 20 years from filing—determines market window.
Conclusion
Patent RU2011142750 embodies a strategically crafted protection for a pharmaceutical innovation, likely at the intersection of chemical novelty and therapeutic utility. Its claims define a scope that balances broad coverage of a chemical entity or method with specific embodiments to withstand legal scrutiny. The patent landscape surrounding it comprises both Russian and international filings, with potential implications for market competition, licensing, and patent infringement risks within the Russian pharmaceutical sector.
Key Takeaways
- Scope of Claims: The patent's legal strength depends on well-defined independent claims balancing breadth with specific limitations to avoid prior art invalidation.
- Patent Landscape Positioning: RU2011142750 fits into a broader ecosystem of patent filings targeting similar chemical entities or therapeutic uses, influencing competition and licensing.
- Strategic Considerations: Effective patent drafting and prosecution are vital for maintaining exclusivity; ongoing monitoring of patent family members is crucial.
- Legal Status and Enforcement: Continued compliance with fee payments and absence of oppositions underpin enforceability within the Russian jurisdiction.
- Market Impact: The patent’s expiration date, claims scope, and enforcement influence eventual generic entry and revenue streams.
FAQs
Q1: What is the typical lifespan of a patent like RU2011142750 within Russia?
A: Generally, pharmaceutical patents in Russia are granted for 20 years from the filing date, although extensions for patent term restoration are possible in certain scenarios.
Q2: How does the scope of claims influence the patent’s market protection?
A: Broad claims extend protection to a wide range of similar compounds or uses, but may be more vulnerable to invalidation. Narrow claims offer stronger defense for specific embodiments but limit market exclusivity.
Q3: Can this patent be challenged or enforced against infringers?
A: Yes, once granted, it can be enforced via litigation. Challenges may be initiated through opposition procedures, but enforcement depends on patent validity and scope.
Q4: How do Russian patent laws compare to those of the US or EPO regarding pharmaceuticals?
A: Russian patent law emphasizes novelty and inventive step, similar to EPO, but specifics differ in definition and procedural aspects, notably in patent term extensions and patentability criteria.
Q5: What strategic actions should patentees consider regarding this patent?
A: Continual monitoring for potential infringing products, planning for patent family expansion, and considering licensing negotiations are key strategies to maximize value.
References
- Russian Federal Service for Intellectual Property (ROSPATENT). Official Patent Documents.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- Russian patent law and procedural guides.
- Industry analyses of pharmaceutical patent strategies in Russia.
[Note: Specific technical details and claim language can be obtained from the official patent document or detailed patent database records for precise legal and technological assessments.]
